Riskpilot← Back to searchSign inGet full accessSøgaard Food and Pharma ApS
APSActiveCVR 35513000Kingstrupvej 46Installation of industrial machinery and equipment · NACE 3320Est. 201324 employeeswww.soegaard.group
Revenue 2024
DKK 4,8M
+81% vs 2023
EBITDA margin
24.5%
-42% vs 2023
Equity ratio
13.3%
Financial strength
Net profit 2024
DKK 558K
-80% vs 2023
| Revenue | DKK 4,8M | +81% |
| EBITDA | DKK 1,2M | -42% |
| Net profit | DKK 558K | -80% |
| Total assets | DKK 15,8M | +278% |
| Equity | DKK 2,1M | +36% |
| Employees | 24 | — |
Legal name
Søgaard Food and Pharma ApS
CVR number
35513000
Legal form
Anpartsselskab
NACE code
3320 · Installation of industrial machinery and equipment
Founded
9. oktober 2013
Share capital
DKK 80.000
Employees
24 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktionen.
Company purpose
Selskabets formål er fremstilling af procesanlæg til industri samt efter ledelsens skøn beslægtede formål.
Address
Kingstrupvej 46
Phone
+4549400270
Email
Jm@sf-p.dk
Website
www.soegaard.group
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | -6 | -8 | -7 | 2.650 | 4.787 |
| Staff expenses | -0 | -0 | -0 | -614 | -3.544 |
| EBITDA | -6 | -8 | -7 | 2.037 | 1.175 |
| Depreciation & amort. | -0 | -0 | -0 | -15 | -303 |
| EBIT | -6 | -8 | -7 | 2.021 | 872 |
| Net financials | -1.745 | 20 | 286 | 1.274 | -154 |
| Profit before tax | -1.751 | 12 | 279 | 3.296 | 718 |
| Tax | -0 | -0 | -8 | 443 | 160 |
| Net profit | -1.751 | 12 | 287 | 2.853 | 558 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1.285 | 1.331 | 1.156 | 4.179 | 15.814 |
| Equity | -1.604 | -1.592 | -1.305 | 1.547 | 2.105 |
| Long-term debt | 2.859 | 2.910 | 2.453 | 0 | 2.513 |
| Short-term debt | 30 | 14 | 8 | 2.617 | 11.021 |
| Total debt | 2.889 | 2.924 | 2.461 | 2.617 | 13.534 |
EBITDA margin
24.5%
This company
15.8%
Market median
+55% vs market
20202024
Equity ratio
13.3%
This company
38.2%
Market median
-65% vs market
20202024
Return on equity
26.5%
This company
18.4%
Market median
+44% vs market
20202024
Net profit margin
11.6%
This company
8.1%
Market median
+43% vs market
20202024
Asset turnover
0.30×
This company
1.12×
Market median
-73% vs market
20202024
Debt / equity
6.51×
This company
0.62×
Market median
-950% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
SS | Founder | 2013 |
JM Chief Executive Officer | Chief Executive Officer | 2023 |
| Former (1) | ||
JS Management | Management | 2024 – 2026 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2026 | |
| Company | 50–66.65% | 50–66.65% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Møllmann Holding ApS
Søgaard Food and Pharma ApS Board members of Søgaard Food and Pharma ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Stefan Skovsende Kilde Søgaard | Founder | 0 companies |
| Jesper Møllmann | Chief Executive Officer | 0 companies |
| Jim Søgaard | Management | 0 companies |